Clinical Trials Directory

Trials / Completed

CompletedNCT00748059

The Pathophysiology of Orthostatic Hypotension

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Vanderbilt University Medical Center · Academic / Other
Sex
All
Age
12 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the cause of low blood pressure in selective patients who have problems with their involuntary (autonomic) nervous system. These patients frequently have had symptoms throughout their life, and their disorder might have a genetic basis. The biochemical, physiological and pharmacological procedures in this study should help us define the problem and perhaps lead to more effective treatment.

Conditions

Interventions

TypeNameDescription
PROCEDUREStanding or upright tiltstand upright or tilt table test
PROCEDUREMicroneurographyRecording from sympathetic nerve
PROCEDUREQSweatquantitative sweat testing
DEVICEneck cuff stimulationBlood pressure receptors in the neck arteries may be stimulated by applying suction through a collar around the neck.
DRUGphenylephrine,isoproterenol,nitroprusside,propranolol,edrophonium,atropine,tyramineIV Pharmacological Testing phenylephrine 12.5 - 400 ug, isoproterenol 0.1 - 0.4 ug or higher until desired effect, nitroprusside 0.1 - 1.6 ug/kg, propranolol 1.1 mg/min, edrophonium maximum of 10 mg, atropine .01 mg/kg, tyramine 250-4000 ug or higher until desired effect
DRUGclonidine,yohimbine,metoclopramide,alpha-methyldopaOral Pharmacological Testing clonidine 0.1-0.3 mg, yohimbine 5-10 mg, metoclopramide 10 mg, alpha-methyldopa 62.5 mg, placebo
PROCEDUREBodPodDetermination of body composition
PROCEDUREEye examExamination of pressure in the eye and eyelid fatiguability. The following eyedrops might be used: 1. 0.5% proparacaine (Alcaine, Allergan, Inc) 2. Fluress (0.4% benoxinate hydrochloride, fluorescein sodium, Akorn, Inc) 3. 0.5%, 1% tropicamide (Mydriacyl, Alcon) 4. Over-the-counter preservative-free artificial tears 5. 0.25%, 2.5% and 10% phenylephrine (Bausch and Lomb) 6. 1% cyclopentolate hydrochloride (Alcon)
PROCEDURESleep studyRecording of sleep pattern overnight
PROCEDUREPain response testingSubjects will rate the quality and intensity of 2 pain tasks.
PROCEDUREMetabolic chamberDetermination of metabolic rate via 24hr stay in whole-room indirect calorimeter
PROCEDUREBrain function studiesQuestionnaires and computer tasks, an EEG and an MRI may be used to assess brain function.
PROCEDUREBicycle Exercise TestBlood pressure and heart rate may be monitored while exercising on a stationary bicycle.

Timeline

Start date
1996-12-01
Primary completion
2020-12-01
Completion
2020-12-01
First posted
2008-09-08
Last updated
2021-05-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00748059. Inclusion in this directory is not an endorsement.